Docking studies of matrix metalloproteinase inhibitors: zinc parameter optimization to improve the binding free energy prediction

被引:109
作者
Hu, X [1 ]
Shelver, WH [1 ]
机构
[1] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA
关键词
docking; AutoDock; matrix metalloproteinase inhibitors; zinc parameters; simplex algorithm; structure-based drug design;
D O I
10.1016/S1093-3263(03)00153-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Docking of metalloproteinase inhibitors remains a challenge due to the zinc multiple coordination geometries and the lack of appropriate force field parameters to model the metal/ligand interactions. In this study, we explore the docking accuracy and scoring reliability for the docking of matrix metalloproteinase (MMP) inhibitors using AutoDock 3.0. Potential problems associated with zinc ion were investigated by docking 16 matrix metalloproteinase ligands to their crystal structures. A good coordination between the zinc binding group (ZBG) and the zinc was shown to be a prerequisite for the ligand to fit the binding site. A simplex optimization of zinc parameters, including zinc radius, well depth, and zinc charges, was performed utilizing the 14 MMP complexes with good docking. The use of optimized zinc parameters (zinc radius: 0.87 Angstrom; well depth: 0.35 kcal/mol; and zinc charges: +0.95 e) shows improvement in both docking accuracy at the zinc binding site and the prediction of bindin free energies. Although further improvement in the docking procedure, particularly the scoring function is needed, optimization of zinc parameters provides an efficient way to improve the performance of AutoDock as a drug discovery tool. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 126
页数:12
相关论文
共 47 条
[1]   Analysis of zinc binding sites in protein crystal structures [J].
Alberts, IL ;
Nadassy, K ;
Wodak, SJ .
PROTEIN SCIENCE, 1998, 7 (08) :1700-1716
[2]   Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: Applying a "divide and conquer" strategy [J].
Amin, EA ;
Welsh, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) :3849-3855
[3]  
[Anonymous], SYBYL MOL MOD SOFTW
[4]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[5]   Recent advances in matrix metalloproteinase inhibitor research [J].
Beckett, RP ;
Davidson, AH ;
Drummond, AH ;
Huxley, P ;
Whittaker, M .
DRUG DISCOVERY TODAY, 1996, 1 (01) :16-26
[6]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[7]   THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY [J].
BODE, W ;
REINEMER, P ;
HUBER, R ;
KLEINE, T ;
SCHNIERER, S ;
TSCHESCHE, H .
EMBO JOURNAL, 1994, 13 (06) :1263-1269
[8]   Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data [J].
Brandstetter, H ;
Engh, RA ;
Von Roedern, EG ;
Moroder, L ;
Huber, R ;
Bode, W ;
Grams, F .
PROTEIN SCIENCE, 1998, 7 (06) :1303-1309
[9]   MATRILYSIN-INHIBITOR COMPLEXES - COMMON THEMES AMONG METALLOPROTEASES [J].
BROWNER, MF ;
SMITH, WW ;
CASTELHANO, AL .
BIOCHEMISTRY, 1995, 34 (20) :6602-6610
[10]   Modified AutoDock for accurate docking of protein kinase inhibitors [J].
Buzko, OV ;
Bishop, AC ;
Shokat, KM .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (02) :113-127